EDGAR Filing Documents for 0001415889-16-006793

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001415889-16-006793

Filing Date

2016-08-12

Accepted

2016-08-12 14:34:19

Documents

Period of Report

2016-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	ecte10q_june302016.htm	10-Q	643568
2	CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE	ex31-1.htm	EX-31.1	11431
3	CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE	ex31-2.htm	EX-31.2	11039
4	CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1	ex32-1.htm	EX-32.1	4897
5	CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1	ex32-2.htm	EX-32.2	4858
	Complete submission text file	0001415889-16-006793.txt		2890471

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	ecte-20160630.xml	EX-101.INS	416845
7	XBRL TAXONOMY EXTENSION SCHEMA	ecte-20160630.xsd	EX-101.SCH	36242
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	ecte-20160630_cal.xml	EX-101.CAL	42654
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	ecte-20160630_def.xml	EX-101.DEF	107455
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ecte-20160630_lab.xml	EX-101.LAB	260269
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ecte-20160630_pre.xml	EX-101.PRE	200958

Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830

Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 732-549-0919

Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)